Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 9, Number 23, 2003

Book review

Favourites:
ADD

Review article

HIF-1α Deficiency Perturbs T and B Cell Functions
pp. 1827-1832(6)
Authors: Kojima, Hidefumi; Sitkovsky, Michail V.; Cascalho, Marilia

Favourites:
ADD

BLyS: The Pivotal Determinant of Peripheral B Cell Selection and Lifespan
pp. 1833-1847(15)
Authors: Smith, Susan H.; Cancro, Michael P.

Favourites:
ADD

Regulation of B-Cell Activation by Complement Receptors CD21 and CD35
pp. 1849-1860(12)
Authors: Erdei, Anna; Prechl, Jozsef; Isaak, Andrea; Molnar, Eszter

Favourites:
ADD
Favourites:
ADD

Regulation of the Immune Response by Natural IgM: Lessons from Warm Autoimmune Hemolytic Anemia
pp. 1871-1880(10)
Authors: Stahl, Dorothea; Sibrowski, Walter

Favourites:
ADD

Antibody Penetration Into Living Cells: Pathogenic, Preventive and Immuno-Therapeutic Implications
pp. 1881-1887(7)
Authors: Ruiz-Arguelles, Alejandro; Rivadeneyra-Espinoza, Liliana; Alarcon-Segovia, Donato

Favourites:
ADD
Favourites:
ADD

Gene Expression Profiles in Human Autoimmune Disease
pp. 1905-1917(13)
Authors: Aune, Thomas M.; Maas, Kevin; Moore, Jason H.; Olsen, Nancy J.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content